40 recruiting. 40 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 40 | Recruiting 40 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease Continuation of daily low-dose Aspirin, Discontinuation of daily low-dose Aspirin - Ischemic Heart Disease, Ischemic Heart Disease Chronic | Phase 4 | Recruiting | Odense University Hospital | 7000 | 2026-09-30 | 2026-10-05 |
| NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke MLC901, Standard treatment for acute ischemic stroke - Stroke, Stroke, Acute Ischemic | Phase 4 | Recruiting | EVD Pharmacy and Medical Company Limited | 80 | 2026-09-10 | 2026-10-20 |
| Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months Prasugrel, Ticagrelor - Myocardial Infarction (MI) | Phase 4 | Recruiting | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 8100 | 2026-09-02 | 2026-09-09 |
| Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia | Phase 4 | Recruiting | Taipei Medical University Hospital | 400 | 2026-08-26 | 2026-09-17 |
| BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis Apixaban, Clopidogrel - Stroke, Ischemic | Phase 4 | Recruiting | Yonsei University | 586 | 2026-07-14 | 2026-10-16 |
| Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure Ketone Monoester (KE) - Acute Heart Failure (AHF), Cardiogenic Shock | Phase 4 | Recruiting | Institute for Clinical and Experimental Medicine | 12 | 2026-04-04 | 2026-04-14 |
| Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome Ferric Carboxymaltose Injection [Ferinject] - Acute Coronary Syndromes (ACS), Iron Deficiencies | Phase 4 | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 538 | 2026-03-05 | 2026-03-24 |
| Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS) | Phase 4 | Recruiting | Instituto Nacional de Cardiologia Ignacio Chavez | 326 | 2026-02-11 | 2026-04-09 |
| Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions Influenza vaccination - Myocardial Infarction, Decompensated Chronic Heart Failure | Phase 4 | Recruiting | Wroclaw Medical University | 400 | 2025-11-12 | 2026-06-01 |
| Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke Mexidol, Glycine - Ischemic Stroke | Phase 4 | Recruiting | Pharmasoft | 120 | 2025-11-04 | 2026-05-13 |
| Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial rt-PA, DAPT - Lacunar Stroke, Stroke | Phase 4 | Recruiting | Nippon Medical School | 500 | 2025-08-01 | 2026-08-04 |
| STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant Experimental: Aspirin monotherapy, Active Comparator: Aspirin+Clopidogrel - Mitral Regurgitation | Phase 4 | Recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 1032 | 2025-07-31 | 2026-03-09 |
| The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis Aspirin, Clopidogrel, Cilostazol - Cerebral Infarction, Stenosis Artery | Phase 4 | Recruiting | Asan Medical Center | 2340 | 2025-07-10 | 2026-03-27 |
| Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation Apixaban, Aspirin - Stroke, Ischemic Stroke | Phase 4 | Recruiting | Assistance Publique - Hôpitaux de Paris | 1148 | 2025-06-18 | 2026-06-05 |
| STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant Experimental: Rivaroxaban monotherapy, Active Comparator: Rivaroxaban+Clopidogrel - Mitral Regurgitation | Phase 4 | Recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 880 | 2025-06-13 | 2026-03-09 |
| Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention Adenosine pre-medication, Standard care - ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon | Phase 4 | Recruiting | National Institute of Cardiovascular Diseases, Pakistan | 1148 | 2025-06-01 | 2026-04-22 |
| Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction Aspirin, Fondaparinux Sodium - NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI) | Phase 4 | Recruiting | University of Aarhus | 5076 | 2025-05-01 | 2026-05-04 |
| STunning in Acute Myocardial Infarction - BAS Bisoprolol Oral Tablet, Ramipril Oral Product, Dapagliflozin Oral Product - Myocardial Infarct | Phase 4 | Recruiting | Vastra Gotaland Region | 120 | 2025-01-06 | 2026-10-13 |
| Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden rhTNK-tPA, 4-8 mg, Tirofiban - ST-segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Recruiting | Henan Institute of Cardiovascular Epidemiology | 300 | 2025-01-01 | 2026-05-22 |
| Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator Early initiation of continuous renal replacement therapy, Standard initiation of continuous renal replacement therapy - Cardiogenic Shock, Acute Kidney Injury | Phase 4 | Recruiting | Samsung Medical Center | 408 | 2024-12-31 | 2026-01-05 |
Showing 20 of 40. Sign in to see all of them.
Myocardial Infarction (17) · ST Elevation Myocardial Infarction (10) · Stroke (8) · Acute Coronary Syndrome (7) · Shock, Cardiogenic (6) · Hemorrhage (4) · Ischemic Stroke (4) · Atrial Fibrillation (3) · Cardiovascular Diseases (3) · Cerebral Infarction (3) · Chronic Limb-Threatening Ischemia (3) · Coronary Artery Disease (3) · Non-ST Elevated Myocardial Infarction (3) · Embolism and Thrombosis (2) · Iron Deficiencies (2)
Pathologic Processes (40) · Pathological Conditions, Signs and Symptoms (40) · Vascular Diseases (39) · Cardiovascular Diseases (36) · Necrosis (34) · Heart Diseases (33) · Infarction (33) · Myocardial Ischemia (30) · Myocardial Infarction (13) · Brain Diseases (10) · Central Nervous System Diseases (10) · Cerebrovascular Disorders (10) · Nervous System Diseases (10) · Arterial Occlusive Diseases (7)
Aspirin (7) · Clopidogrel (5) · Rivaroxaban (5) · Ezetimibe (3) · 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (2) · Ticagrelor (2) · apixaban (2) · ferric carboxymaltose (2) · 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Arginine Vasopressin (1) · Atorvastatin (1) · BID protein, human (1) · Bisoprolol (1) · Cilostazol (1)
Samsung Medical Center (3) · Cell Biopeutics Resources Sdn Bhd (2) · Chinese Academy of Medical Sciences, Fuwai Hospital (2) · Wroclaw Medical University (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Asan Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Duk-Woo Park, MD (1) · EVD Pharmacy and Medical Company Limited (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Henan Institute of Cardiovascular Epidemiology (1) · Institute for Clinical and Experimental Medicine (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1) · Kindai University (1)
South Korea (8) · China (5) · Denmark (3) · Netherlands (3) · Poland (3) · Belgium (2) · Brazil (2) · Czechia (2) · Japan (2) · Malaysia (2) · Russia (2) · Spain (2) · Canada (1) · France (1) · Germany (1)
Hanafiah Harunarashid, MS (2) · Xiangbin Pan, MD,PhD (2) · Borja Ibanez, MD PhD (1) · Cai De Jin, MD (1) · Chun-Yao Huang, MD, PhD (1) · Chunjian Li, PHD (1) · Eduardo Ramacciotti, MD, Ph.D. (1) · Gaku Nakazawa, MD, PhD (1) · Jan Biegus, Professor (1) · Jeong Hoon Yang, MD (1) · Joo-Yong Hahn, MD,PhD (1) · Kiyuk Chang, MD,PhD (1) · Ludhmila A Hajjar, Full Professor (1)
PMID 41616808, PMID 39007830, PMID 39645270, PMID 40015616, PMID 40188976, PMID 40375771, PMID 40945808, PMID 41198200, PMID 41232756, PMID 41436299, PMID 41910427, PMID 42651065, PMID 42670955